Rank | Gene Set | Z-score |
---|---|---|
1 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 9.31616855 |
2 | angiotensin maturation (GO:0002003) | 7.24622484 |
3 | bile acid and bile salt transport (GO:0015721) | 6.64369331 |
4 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 5.87701514 |
5 | intestinal absorption (GO:0050892) | 5.78737990 |
6 | maintenance of gastrointestinal epithelium (GO:0030277) | 5.78498736 |
7 | sulfur amino acid catabolic process (GO:0000098) | 5.26838339 |
8 | regulation of bile acid biosynthetic process (GO:0070857) | 5.13239442 |
9 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 5.04556636 |
10 | cellular glucuronidation (GO:0052695) | 5.02297819 |
11 | regulation of vitamin metabolic process (GO:0030656) | 4.96188096 |
12 | glycosphingolipid catabolic process (GO:0046479) | 4.93359637 |
13 | fat-soluble vitamin biosynthetic process (GO:0042362) | 4.85231632 |
14 | O-glycan processing (GO:0016266) | 4.79374101 |
15 | flavonoid metabolic process (GO:0009812) | 4.73781624 |
16 | epithelial structure maintenance (GO:0010669) | 4.70655302 |
17 | regulation of mononuclear cell migration (GO:0071675) | 4.68206895 |
18 | glycolipid catabolic process (GO:0019377) | 4.65015559 |
19 | intestinal epithelial cell development (GO:0060576) | 4.57638082 |
20 | uronic acid metabolic process (GO:0006063) | 4.55051018 |
21 | glucuronate metabolic process (GO:0019585) | 4.55051018 |
22 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 4.38269031 |
23 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 4.38269031 |
24 | adhesion of symbiont to host cell (GO:0044650) | 4.35540882 |
25 | virion attachment to host cell (GO:0019062) | 4.35540882 |
26 | regulation of cellular extravasation (GO:0002691) | 4.35474327 |
27 | regulation of guanylate cyclase activity (GO:0031282) | 4.20943410 |
28 | immunoglobulin mediated immune response (GO:0016064) | 4.19618638 |
29 | eosinophil chemotaxis (GO:0048245) | 4.17399458 |
30 | lipoprotein transport (GO:0042953) | 4.04393657 |
31 | ceramide catabolic process (GO:0046514) | 3.94533891 |
32 | peptide catabolic process (GO:0043171) | 3.92603959 |
33 | regulation of cholesterol homeostasis (GO:2000188) | 3.91706467 |
34 | xenobiotic catabolic process (GO:0042178) | 3.90789288 |
35 | nucleotide-sugar biosynthetic process (GO:0009226) | 3.88799045 |
36 | bile acid metabolic process (GO:0008206) | 3.88103891 |
37 | nucleotide-sugar metabolic process (GO:0009225) | 3.82583577 |
38 | actin filament depolymerization (GO:0030042) | 3.80345462 |
39 | hypotonic response (GO:0006971) | 3.78001718 |
40 | thrombin receptor signaling pathway (GO:0070493) | 3.76789910 |
41 | regulation of vitamin D biosynthetic process (GO:0060556) | 3.76050767 |
42 | sulfation (GO:0051923) | 3.74903730 |
43 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.74151512 |
44 | hemidesmosome assembly (GO:0031581) | 3.71043558 |
45 | digestive system process (GO:0022600) | 3.69888308 |
46 | eosinophil migration (GO:0072677) | 3.69780679 |
47 | kidney morphogenesis (GO:0060993) | 3.68153186 |
48 | membrane lipid catabolic process (GO:0046466) | 3.68122184 |
49 | adhesion of symbiont to host (GO:0044406) | 3.68004817 |
50 | oligosaccharide catabolic process (GO:0009313) | 3.67379510 |
51 | sphingolipid catabolic process (GO:0030149) | 3.66231865 |
52 | NADH metabolic process (GO:0006734) | 3.63222665 |
53 | homocysteine metabolic process (GO:0050667) | 3.59758517 |
54 | positive regulation of actin filament depolymerization (GO:0030836) | 3.58929103 |
55 | extracellular matrix assembly (GO:0085029) | 3.53958599 |
56 | epoxygenase P450 pathway (GO:0019373) | 3.53064953 |
57 | regulation of macrophage chemotaxis (GO:0010758) | 3.53004718 |
58 | fructose metabolic process (GO:0006000) | 3.47218083 |
59 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.45822599 |
60 | positive regulation of antigen processing and presentation (GO:0002579) | 3.44785034 |
61 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.40225066 |
62 | regulation of antigen processing and presentation (GO:0002577) | 3.38029624 |
63 | response to nitrosative stress (GO:0051409) | 3.37650623 |
64 | drug catabolic process (GO:0042737) | 3.37243476 |
65 | T-helper 1 type immune response (GO:0042088) | 3.35782723 |
66 | regulation of cytokine secretion involved in immune response (GO:0002739) | 3.35584713 |
67 | phospholipid homeostasis (GO:0055091) | 3.35356850 |
68 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.32329169 |
69 | sulfate transmembrane transport (GO:1902358) | 3.31013769 |
70 | negative regulation of interleukin-12 production (GO:0032695) | 3.26570844 |
71 | intestinal cholesterol absorption (GO:0030299) | 3.24355651 |
72 | midgut development (GO:0007494) | 3.24133721 |
73 | production of molecular mediator of immune response (GO:0002440) | 3.22708938 |
74 | hepatocyte apoptotic process (GO:0097284) | 3.20992090 |
75 | ethanol metabolic process (GO:0006067) | 3.15364771 |
76 | branching involved in labyrinthine layer morphogenesis (GO:0060670) | 3.09957633 |
77 | cGMP-mediated signaling (GO:0019934) | 3.09188300 |
78 | drug transmembrane transport (GO:0006855) | 3.04269042 |
79 | regulation of systemic arterial blood pressure mediated by a chemical signal (GO:0003044) | 3.03826197 |
80 | endocrine process (GO:0050886) | 3.03826197 |
81 | regulation of systemic arterial blood pressure by hormone (GO:0001990) | 3.03826197 |
82 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.03798344 |
83 | regulation of podosome assembly (GO:0071801) | 3.02797937 |
84 | B cell mediated immunity (GO:0019724) | 3.01602270 |
85 | positive regulation of guanylate cyclase activity (GO:0031284) | 3.00605791 |
86 | respiratory tube development (GO:0030323) | 2.96874533 |
87 | exogenous drug catabolic process (GO:0042738) | 2.95887412 |
88 | endocardial cushion development (GO:0003197) | 2.94625955 |
89 | NIK/NF-kappaB signaling (GO:0038061) | 2.93169166 |
90 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.92740817 |
91 | cellular response to type I interferon (GO:0071357) | 2.91948736 |
92 | type I interferon signaling pathway (GO:0060337) | 2.91948736 |
93 | phospholipid efflux (GO:0033700) | 2.91745802 |
94 | cellular response to interferon-gamma (GO:0071346) | 2.91003481 |
95 | regulation of cholesterol storage (GO:0010885) | 2.90220713 |
96 | transcytosis (GO:0045056) | 2.89945427 |
97 | response to type I interferon (GO:0034340) | 2.88480543 |
98 | positive regulation of pseudopodium assembly (GO:0031274) | 2.87476275 |
99 | desmosome organization (GO:0002934) | 2.86925917 |
100 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.86169845 |
101 | mesodermal cell differentiation (GO:0048333) | 2.85953551 |
102 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.84193416 |
103 | protein O-linked glycosylation (GO:0006493) | 2.82652166 |
104 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.82559322 |
105 | detection of other organism (GO:0098543) | 2.79038094 |
106 | monocyte chemotaxis (GO:0002548) | 2.76315690 |
107 | macrophage activation involved in immune response (GO:0002281) | 2.75467427 |
108 | diacylglycerol metabolic process (GO:0046339) | 2.75005924 |
109 | ventricular cardiac muscle cell action potential (GO:0086005) | 2.74150322 |
110 | response to interferon-gamma (GO:0034341) | 2.73851486 |
111 | regulation of cell-cell adhesion mediated by cadherin (GO:2000047) | 2.73799180 |
112 | myeloid dendritic cell differentiation (GO:0043011) | 2.73304027 |
113 | urea metabolic process (GO:0019627) | 2.73300361 |
114 | urea cycle (GO:0000050) | 2.73300361 |
115 | regulation of systemic arterial blood pressure (GO:0003073) | 2.72900623 |
116 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.72809872 |
117 | positive regulation of type 2 immune response (GO:0002830) | 2.72283007 |
118 | neutrophil activation involved in immune response (GO:0002283) | 2.71329107 |
119 | cyclooxygenase pathway (GO:0019371) | 2.69625525 |
120 | hormone catabolic process (GO:0042447) | 2.69542105 |
121 | very-low-density lipoprotein particle assembly (GO:0034379) | 2.68874065 |
122 | detection of bacterium (GO:0016045) | 2.67846816 |
123 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.67672845 |
124 | lipid translocation (GO:0034204) | 2.67598431 |
125 | phospholipid translocation (GO:0045332) | 2.67598431 |
126 | nucleotide transmembrane transport (GO:1901679) | 2.65485619 |
127 | primary alcohol catabolic process (GO:0034310) | 2.64800518 |
128 | response to peptidoglycan (GO:0032494) | 2.64598368 |
129 | benzene-containing compound metabolic process (GO:0042537) | 2.64417156 |
130 | relaxation of cardiac muscle (GO:0055119) | 2.63707045 |
131 | renal system process involved in regulation of blood volume (GO:0001977) | 2.63667480 |
132 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.63512461 |
133 | peptide hormone processing (GO:0016486) | 2.62642551 |
134 | regulation of cGMP biosynthetic process (GO:0030826) | 2.61566318 |
135 | drug metabolic process (GO:0017144) | 2.61549567 |
136 | bicarbonate transport (GO:0015701) | 2.59293181 |
137 | glutathione derivative biosynthetic process (GO:1901687) | 2.57675873 |
138 | glutathione derivative metabolic process (GO:1901685) | 2.57675873 |
139 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.56375409 |
140 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.56375409 |
141 | lipoprotein metabolic process (GO:0042157) | 2.56337773 |
142 | regulation of chemokine biosynthetic process (GO:0045073) | 2.55076368 |
143 | negative regulation of steroid metabolic process (GO:0045939) | 2.54857440 |
144 | regulation of fever generation (GO:0031620) | 2.54357588 |
145 | regulation of pseudopodium assembly (GO:0031272) | 2.53442401 |
146 | transepithelial transport (GO:0070633) | 2.52963886 |
147 | low-density lipoprotein particle remodeling (GO:0034374) | 2.52511022 |
148 | alpha-linolenic acid metabolic process (GO:0036109) | 2.52393181 |
149 | cell adhesion mediated by integrin (GO:0033627) | 2.52299541 |
150 | lung secretory cell differentiation (GO:0061140) | 2.52168790 |
151 | glucose 6-phosphate metabolic process (GO:0051156) | 2.49827259 |
152 | positive regulation of heat generation (GO:0031652) | 2.49367388 |
153 | regulation of cholesterol esterification (GO:0010872) | 2.49033103 |
154 | sulfate transport (GO:0008272) | 2.48894005 |
155 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.48715631 |
156 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 2.48570121 |
157 | cellular ketone body metabolic process (GO:0046950) | 2.47785004 |
158 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.46877159 |
159 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.46205085 |
160 | complement activation, classical pathway (GO:0006958) | 2.45071747 |
161 | negative regulation of sterol transport (GO:0032372) | 2.44911850 |
162 | negative regulation of cholesterol transport (GO:0032375) | 2.44911850 |
163 | vitamin D metabolic process (GO:0042359) | 2.44674965 |
164 | amino sugar metabolic process (GO:0006040) | 2.44166077 |
165 | lung vasculature development (GO:0060426) | 2.44102247 |
166 | antibacterial humoral response (GO:0019731) | 2.43324498 |
167 | cell communication involved in cardiac conduction (GO:0086065) | 2.42804509 |
168 | dendritic cell chemotaxis (GO:0002407) | 2.42691346 |
169 | receptor guanylyl cyclase signaling pathway (GO:0007168) | 2.42628611 |
170 | plasma lipoprotein particle assembly (GO:0034377) | 2.42393033 |
171 | drug transport (GO:0015893) | 2.41719263 |
172 | protein-lipid complex assembly (GO:0065005) | 2.39812535 |
173 | ethanol oxidation (GO:0006069) | 2.39211017 |
174 | alkaloid metabolic process (GO:0009820) | 2.38598497 |
175 | antimicrobial humoral response (GO:0019730) | 2.38591309 |
176 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.38349625 |
177 | sterol homeostasis (GO:0055092) | 2.38242360 |
178 | cholesterol homeostasis (GO:0042632) | 2.38186157 |
179 | lung lobe morphogenesis (GO:0060463) | 2.37889378 |
180 | apoptotic cell clearance (GO:0043277) | 2.34852229 |
181 | nitrogen cycle metabolic process (GO:0071941) | 2.33776778 |
182 | galactose catabolic process (GO:0019388) | 2.33568819 |
183 | negative regulation of steroid biosynthetic process (GO:0010894) | 2.33062394 |
184 | establishment of epithelial cell polarity (GO:0090162) | 2.32176763 |
185 | xenobiotic metabolic process (GO:0006805) | 2.30507230 |
186 | growth hormone receptor signaling pathway (GO:0060396) | 2.29760993 |
187 | sulfur compound transport (GO:0072348) | 2.28805950 |
Rank | Gene Set | Z-score |
---|---|---|
1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.44928279 |
2 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 4.88989699 |
3 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 4.53135164 |
4 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.22628798 |
5 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 3.71554307 |
6 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.69988588 |
7 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 3.17479374 |
8 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.06733363 |
9 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 3.02753359 |
10 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.02279150 |
11 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.92271946 |
12 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.91508276 |
13 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.88142636 |
14 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.80254656 |
15 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 2.71298177 |
16 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.70386552 |
17 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.69763420 |
18 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.69043904 |
19 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.49946761 |
20 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.47308117 |
21 | SOX2_20726797_ChIP-Seq_SW620_Human | 2.23469537 |
22 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 2.20972125 |
23 | GATA1_22025678_ChIP-Seq_K562_Human | 2.15300869 |
24 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.15285940 |
25 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.15222168 |
26 | GATA4_25053715_ChIP-Seq_YYC3_Human | 2.07266512 |
27 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 2.04822133 |
28 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 2.01955240 |
29 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.98425651 |
30 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.98423846 |
31 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.97990837 |
32 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.96605197 |
33 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.96061674 |
34 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.94838851 |
35 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.92672116 |
36 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.91485718 |
37 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.90465599 |
38 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.87449840 |
39 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.87004744 |
40 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.86920322 |
41 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.86881356 |
42 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.83440671 |
43 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.78044097 |
44 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.75270483 |
45 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.74340575 |
46 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.73398023 |
47 | * VDR_24763502_ChIP-Seq_THP-1_Human | 1.65051337 |
48 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.62004009 |
49 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.61470396 |
50 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.56133268 |
51 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.55779046 |
52 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.52178990 |
53 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.50805356 |
54 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.50603751 |
55 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.50603751 |
56 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.50020421 |
57 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.47187256 |
58 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.42850114 |
59 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.42740299 |
60 | SPI1_23127762_ChIP-Seq_K562_Human | 1.42347913 |
61 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.41855381 |
62 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.40382366 |
63 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.38171265 |
64 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.37843193 |
65 | KLF5_25053715_ChIP-Seq_YYC3_Human | 1.37069827 |
66 | * ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.35550168 |
67 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.35357760 |
68 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.32951299 |
69 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.31187785 |
70 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.30209070 |
71 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.30121726 |
72 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.29936778 |
73 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.29679258 |
74 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.24053583 |
75 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.23602923 |
76 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.23448267 |
77 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.23372902 |
78 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.22554914 |
79 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.22299122 |
80 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.22231301 |
81 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.21473331 |
82 | CJUN_26792858_Chip-Seq_BT549_Human | 1.20976387 |
83 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.20571699 |
84 | TP53_16413492_ChIP-PET_HCT116_Human | 1.20338121 |
85 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.18895171 |
86 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.18895171 |
87 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.18458851 |
88 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.18443637 |
89 | * AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.18036327 |
90 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.16862736 |
91 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.16449112 |
92 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.15907149 |
93 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.14328446 |
94 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.14284441 |
95 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.13285063 |
96 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.13263302 |
97 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.12011515 |
98 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.11662320 |
99 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.11438034 |
100 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 1.11168156 |
101 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.09360452 |
102 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.09360452 |
103 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.09360452 |
104 | GATA2_19941826_ChIP-Seq_K562_Human | 1.09159353 |
105 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.09006988 |
106 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.08984789 |
107 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.08025447 |
108 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.07744992 |
109 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.07445912 |
110 | RXR_22108803_ChIP-Seq_LS180_Human | 1.07089415 |
111 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.06828778 |
112 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.05303988 |
113 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.03355316 |
114 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 1.02913770 |
115 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.02514754 |
116 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.02200302 |
117 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.01967716 |
118 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.01821638 |
119 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.99634100 |
120 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.99509183 |
121 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.99267317 |
122 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.98665063 |
123 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.97950411 |
124 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.97586770 |
125 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.96983156 |
126 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 0.96474966 |
127 | GATA1_19941826_ChIP-Seq_K562_Human | 0.96361557 |
128 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.96356745 |
129 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.96326399 |
130 | * VDR_24787735_ChIP-Seq_THP-1_Human | 0.96245309 |
131 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.95867680 |
132 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.95789850 |
133 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.95057217 |
134 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.94745375 |
135 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.94726556 |
136 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.94207820 |
137 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.93897972 |
138 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.92076660 |
139 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.91633889 |
140 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.90376493 |
141 | SA1_27219007_Chip-Seq_Bcells_Human | 0.90264520 |
142 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.89261303 |
143 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.88835576 |
144 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.88284524 |
145 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.87933815 |
146 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.86934145 |
147 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.86583130 |
148 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.84574180 |
149 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.83948628 |
150 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 0.83866909 |
151 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.83823799 |
152 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.83371485 |
153 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.82706270 |
154 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.81858174 |
155 | MYB_26560356_Chip-Seq_TH2_Human | 0.80568214 |
156 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 0.80392354 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0005085_abnormal_gallbladder_physiolo | 4.92593204 |
2 | MP0005365_abnormal_bile_salt | 4.45924890 |
3 | MP0010234_abnormal_vibrissa_follicle | 4.04221385 |
4 | MP0005360_urolithiasis | 3.90664692 |
5 | MP0001666_abnormal_nutrient_absorption | 3.66281538 |
6 | MP0008875_abnormal_xenobiotic_pharmacok | 3.60533043 |
7 | MP0004264_abnormal_extraembryonic_tissu | 3.20843603 |
8 | MP0000462_abnormal_digestive_system | 3.14606117 |
9 | MP0006054_spinal_hemorrhage | 2.95895973 |
10 | MP0003866_abnormal_defecation | 2.92438005 |
11 | MP0003183_abnormal_peptide_metabolism | 2.85595793 |
12 | MP0005058_abnormal_lysosome_morphology | 2.80890783 |
13 | MP0002139_abnormal_hepatobiliary_system | 2.77247907 |
14 | MP0001873_stomach_inflammation | 2.74889459 |
15 | MP0003252_abnormal_bile_duct | 2.74544665 |
16 | MP0010155_abnormal_intestine_physiology | 2.72746928 |
17 | MP0003300_gastrointestinal_ulcer | 2.69048263 |
18 | MP0006082_CNS_inflammation | 2.68394929 |
19 | MP0001835_abnormal_antigen_presentation | 2.66151815 |
20 | MP0009785_altered_susceptibility_to | 2.57565207 |
21 | MP0002148_abnormal_hypersensitivity_rea | 2.57424630 |
22 | MP0001663_abnormal_digestive_system | 2.50743398 |
23 | MP0002822_catalepsy | 2.48443313 |
24 | MP0003868_abnormal_feces_composition | 2.46934967 |
25 | MP0003436_decreased_susceptibility_to | 2.45698807 |
26 | MP0010352_gastrointestinal_tract_polyps | 2.45386259 |
27 | MP0005381_digestive/alimentary_phenotyp | 2.41879637 |
28 | MP0005671_abnormal_response_to | 2.21684775 |
29 | MP0001790_abnormal_immune_system | 2.16124681 |
30 | MP0005387_immune_system_phenotype | 2.16124681 |
31 | MP0001664_abnormal_digestion | 2.10977991 |
32 | MP0005025_abnormal_response_to | 2.05663571 |
33 | MP0003705_abnormal_hypodermis_morpholog | 2.03494728 |
34 | MP0005167_abnormal_blood-brain_barrier | 2.01077407 |
35 | MP0000604_amyloidosis | 2.00244376 |
36 | MP0005000_abnormal_immune_tolerance | 1.93053095 |
37 | MP0002419_abnormal_innate_immunity | 1.87544571 |
38 | MP0000477_abnormal_intestine_morphology | 1.77469870 |
39 | MP0008004_abnormal_stomach_pH | 1.76491775 |
40 | MP0003191_abnormal_cellular_cholesterol | 1.70935799 |
41 | MP0000537_abnormal_urethra_morphology | 1.65546380 |
42 | MP0002254_reproductive_system_inflammat | 1.64702055 |
43 | MP0010329_abnormal_lipoprotein_level | 1.63175154 |
44 | MP0003806_abnormal_nucleotide_metabolis | 1.61784505 |
45 | MP0002452_abnormal_antigen_presenting | 1.61617118 |
46 | MP0005451_abnormal_body_composition | 1.61362903 |
47 | MP0001800_abnormal_humoral_immune | 1.59778866 |
48 | MP0001533_abnormal_skeleton_physiology | 1.56200152 |
49 | MP0005275_abnormal_skin_tensile | 1.53101298 |
50 | MP0002723_abnormal_immune_serum | 1.52231860 |
51 | MP0000685_abnormal_immune_system | 1.51808487 |
52 | MP0003303_peritoneal_inflammation | 1.51383773 |
53 | MP0003172_abnormal_lysosome_physiology | 1.48160479 |
54 | MP0008469_abnormal_protein_level | 1.47839469 |
55 | MP0003878_abnormal_ear_physiology | 1.46433247 |
56 | MP0005377_hearing/vestibular/ear_phenot | 1.46433247 |
57 | MP0000538_abnormal_urinary_bladder | 1.42418807 |
58 | MP0000465_gastrointestinal_hemorrhage | 1.40667974 |
59 | MP0000343_altered_response_to | 1.39984526 |
60 | MP0004510_myositis | 1.38848698 |
61 | MP0004147_increased_porphyrin_level | 1.35329576 |
62 | MP0000490_abnormal_crypts_of | 1.34299985 |
63 | MP0002060_abnormal_skin_morphology | 1.33232792 |
64 | MP0003566_abnormal_cell_adhesion | 1.31105621 |
65 | MP0008438_abnormal_cutaneous_collagen | 1.30974245 |
66 | MP0002998_abnormal_bone_remodeling | 1.30939266 |
67 | MP0001819_abnormal_immune_cell | 1.28032504 |
68 | MP0003448_altered_tumor_morphology | 1.26583770 |
69 | MP0002420_abnormal_adaptive_immunity | 1.25497174 |
70 | MP0002277_abnormal_respiratory_mucosa | 1.25478214 |
71 | MP0003724_increased_susceptibility_to | 1.21548476 |
72 | MP0009053_abnormal_anal_canal | 1.19423679 |
73 | MP0003941_abnormal_skin_development | 1.15858614 |
74 | MP0009379_abnormal_foot_pigmentation | 1.11219953 |
75 | MP0009333_abnormal_splenocyte_physiolog | 1.10302285 |
76 | MP0000470_abnormal_stomach_morphology | 1.09479636 |
77 | MP0010678_abnormal_skin_adnexa | 1.09300091 |
78 | MP0003453_abnormal_keratinocyte_physiol | 1.09134678 |
79 | MP0000609_abnormal_liver_physiology | 1.08925269 |
80 | MP0000467_abnormal_esophagus_morphology | 1.06897313 |
81 | MP0003329_amyloid_beta_deposits | 1.06424224 |
82 | MP0004947_skin_inflammation | 1.06192767 |
83 | MP0009384_cardiac_valve_regurgitation | 1.05238541 |
84 | MP0002166_altered_tumor_susceptibility | 1.04607026 |
85 | MP0010368_abnormal_lymphatic_system | 1.03197061 |
86 | MP0001764_abnormal_homeostasis | 1.02292084 |
87 | MP0002877_abnormal_melanocyte_morpholog | 1.00098017 |
88 | MP0005409_darkened_coat_color | 0.93839990 |
89 | MP0009643_abnormal_urine_homeostasis | 0.93781656 |
90 | MP0009840_abnormal_foam_cell | 0.92942088 |
91 | MP0000858_altered_metastatic_potential | 0.92775938 |
92 | MP0001853_heart_inflammation | 0.90435599 |
93 | MP0001765_abnormal_ion_homeostasis | 0.90199849 |
94 | MP0001849_ear_inflammation | 0.89477092 |
95 | MP0001501_abnormal_sleep_pattern | 0.89396173 |
96 | MP0002138_abnormal_hepatobiliary_system | 0.89097043 |
97 | MP0005332_abnormal_amino_acid | 0.88873921 |
98 | MP0005166_decreased_susceptibility_to | 0.88345704 |
99 | MP0005464_abnormal_platelet_physiology | 0.87128208 |
100 | MP0004019_abnormal_vitamin_homeostasis | 0.85718817 |
101 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.85507443 |
102 | MP0005408_hypopigmentation | 0.84628025 |
103 | MP0000716_abnormal_immune_system | 0.84612796 |
104 | MP0003879_abnormal_hair_cell | 0.84583167 |
105 | MP0002118_abnormal_lipid_homeostasis | 0.84017332 |
106 | MP0005023_abnormal_wound_healing | 0.83718149 |
107 | MP0000249_abnormal_blood_vessel | 0.83593002 |
108 | MP0002405_respiratory_system_inflammati | 0.82889240 |
109 | MP0004858_abnormal_nervous_system | 0.82361275 |
110 | MP0005319_abnormal_enzyme/_coenzyme | 0.82175875 |
111 | MP0004043_abnormal_pH_regulation | 0.81253205 |
112 | MP0002796_impaired_skin_barrier | 0.80664047 |
113 | MP0003690_abnormal_glial_cell | 0.80459175 |
114 | MP0005165_increased_susceptibility_to | 0.80126511 |
115 | MP0003045_fibrosis | 0.78873632 |
116 | MP0009764_decreased_sensitivity_to | 0.78472665 |
117 | MP0000613_abnormal_salivary_gland | 0.78297099 |
118 | MP0005535_abnormal_body_temperature | 0.77492403 |
119 | MP0002006_tumorigenesis | 0.76797100 |
120 | MP0003091_abnormal_cell_migration | 0.76772405 |
121 | MP0005248_abnormal_Harderian_gland | 0.74338608 |
122 | MP0009763_increased_sensitivity_to | 0.73766291 |
123 | MP0002098_abnormal_vibrissa_morphology | 0.73747448 |
124 | MP0001845_abnormal_inflammatory_respons | 0.73171556 |
125 | MP0001756_abnormal_urination | 0.72326444 |
126 | MP0000678_abnormal_parathyroid_gland | 0.71280104 |
127 | MP0004272_abnormal_basement_membrane | 0.70027266 |
128 | MP0008873_increased_physiological_sensi | 0.69589529 |
129 | MP0005636_abnormal_mineral_homeostasis | 0.69202050 |
130 | MP0003075_altered_response_to | 0.67287389 |
131 | MP0000920_abnormal_myelination | 0.66783206 |
132 | MP0005187_abnormal_penis_morphology | 0.63723997 |
133 | MP0010030_abnormal_orbit_morphology | 0.62582989 |
134 | MP0001243_abnormal_dermal_layer | 0.61666057 |
135 | MP0001216_abnormal_epidermal_layer | 0.61446965 |
136 | MP0002896_abnormal_bone_mineralization | 0.59968429 |
137 | MP0008872_abnormal_physiological_respon | 0.57271888 |
138 | MP0002136_abnormal_kidney_physiology | 0.56202067 |
139 | MP0003283_abnormal_digestive_organ | 0.52690871 |
140 | MP0000762_abnormal_tongue_morphology | 0.52685664 |
141 | MP0002009_preneoplasia | 0.51306938 |
142 | MP0005310_abnormal_salivary_gland | 0.49217757 |
143 | MP0005076_abnormal_cell_differentiation | 0.48298988 |
144 | MP0010386_abnormal_urinary_bladder | 0.47826012 |
145 | MP0005083_abnormal_biliary_tract | 0.47235103 |
146 | MP0004130_abnormal_muscle_cell | 0.46649119 |
147 | MP0009278_abnormal_bone_marrow | 0.44723633 |
148 | MP0003385_abnormal_body_wall | 0.44500262 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Systemic lupus erythematosus (HP:0002725) | 7.22067072 |
2 | Ileus (HP:0002595) | 6.86773378 |
3 | Right ventricular cardiomyopathy (HP:0011663) | 6.17047071 |
4 | Abnormality of liposaccharide metabolism (HP:0010968) | 5.28213048 |
5 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 5.28213048 |
6 | Abnormality of glycolipid metabolism (HP:0010969) | 5.28213048 |
7 | Aortic aneurysm (HP:0004942) | 4.75134685 |
8 | Intrahepatic cholestasis (HP:0001406) | 4.61411423 |
9 | Conjugated hyperbilirubinemia (HP:0002908) | 4.33577404 |
10 | Fat malabsorption (HP:0002630) | 4.25108565 |
11 | Vacuolated lymphocytes (HP:0001922) | 4.24799865 |
12 | Glomerulonephritis (HP:0000099) | 4.14570106 |
13 | Gastrointestinal dysmotility (HP:0002579) | 4.11531050 |
14 | Rectal prolapse (HP:0002035) | 3.95253289 |
15 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.85198601 |
16 | Chronic diarrhea (HP:0002028) | 3.74341253 |
17 | Abnormality of macrophages (HP:0004311) | 3.73361160 |
18 | Aortic dissection (HP:0002647) | 3.68726794 |
19 | Increased connective tissue (HP:0009025) | 3.59204104 |
20 | Malnutrition (HP:0004395) | 3.52502747 |
21 | Recurrent bacterial skin infections (HP:0005406) | 3.48523827 |
22 | Dysostosis multiplex (HP:0000943) | 3.47679125 |
23 | Mildly elevated creatine phosphokinase (HP:0008180) | 3.40726554 |
24 | Flat acetabular roof (HP:0003180) | 3.40130224 |
25 | Disinhibition (HP:0000734) | 3.36728938 |
26 | Nausea (HP:0002018) | 3.29827402 |
27 | Increased cerebral lipofuscin (HP:0011813) | 3.25333470 |
28 | Recurrent abscess formation (HP:0002722) | 3.24347411 |
29 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.14910299 |
30 | Loss of speech (HP:0002371) | 3.12930030 |
31 | Abdominal distention (HP:0003270) | 3.06803255 |
32 | Widely patent fontanelles and sutures (HP:0004492) | 2.99998932 |
33 | Abnormal biliary tract morphology (HP:0012440) | 2.97812667 |
34 | Milia (HP:0001056) | 2.97301070 |
35 | Abnormality of complement system (HP:0005339) | 2.95357546 |
36 | Hyperactive renin-angiotensin system (HP:0000841) | 2.95084228 |
37 | Steatorrhea (HP:0002570) | 2.89437326 |
38 | Abnormality of the distal phalanx of the thumb (HP:0009617) | 2.84970540 |
39 | Thin bony cortex (HP:0002753) | 2.81919277 |
40 | Ankle contracture (HP:0006466) | 2.80370129 |
41 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.79781419 |
42 | Osteolytic defects of the hand bones (HP:0009699) | 2.79781419 |
43 | Axonal loss (HP:0003447) | 2.78016268 |
44 | Orchitis (HP:0100796) | 2.77719505 |
45 | Gingivitis (HP:0000230) | 2.76222630 |
46 | Atrophic scars (HP:0001075) | 2.74804182 |
47 | Deep venous thrombosis (HP:0002625) | 2.72435868 |
48 | Autoimmune thrombocytopenia (HP:0001973) | 2.71073823 |
49 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.70809214 |
50 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.70809214 |
51 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.70809214 |
52 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.70720628 |
53 | Mucopolysacchariduria (HP:0008155) | 2.70720628 |
54 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 2.67635251 |
55 | Metaphyseal irregularity (HP:0003025) | 2.65685619 |
56 | Mutism (HP:0002300) | 2.63663087 |
57 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.62821175 |
58 | Broad metatarsal (HP:0001783) | 2.62324880 |
59 | Aplasia/Hypoplasia of the 4th metacarpal (HP:0010042) | 2.59363333 |
60 | Short 4th metacarpal (HP:0010044) | 2.59363333 |
61 | Nephritis (HP:0000123) | 2.57948842 |
62 | Premature loss of primary teeth (HP:0006323) | 2.56055889 |
63 | Abnormal cartilage morphology (HP:0002763) | 2.54662816 |
64 | Esophageal varix (HP:0002040) | 2.53054685 |
65 | Decreased circulating renin level (HP:0003351) | 2.50262485 |
66 | Xanthomatosis (HP:0000991) | 2.49304420 |
67 | Mediastinal lymphadenopathy (HP:0100721) | 2.47452520 |
68 | Abnormality of vitamin B metabolism (HP:0004340) | 2.46802926 |
69 | Biliary tract neoplasm (HP:0100574) | 2.45033676 |
70 | Hypobetalipoproteinemia (HP:0003563) | 2.42172417 |
71 | Hyperparathyroidism (HP:0000843) | 2.41255800 |
72 | Palpitations (HP:0001962) | 2.40053490 |
73 | Myositis (HP:0100614) | 2.38926002 |
74 | Abnormality of chloride homeostasis (HP:0011422) | 2.37638931 |
75 | Hypophosphatemia (HP:0002148) | 2.37160087 |
76 | Myocardial infarction (HP:0001658) | 2.36712002 |
77 | Abnormal foot bone ossification (HP:0010675) | 2.36508695 |
78 | Optic neuritis (HP:0100653) | 2.36045480 |
79 | Retrobulbar optic neuritis (HP:0100654) | 2.36045480 |
80 | Alopecia of scalp (HP:0002293) | 2.34670338 |
81 | Metabolic alkalosis (HP:0200114) | 2.34658554 |
82 | Urethral obstruction (HP:0000796) | 2.32334861 |
83 | Hemorrhage of the eye (HP:0011885) | 2.31796408 |
84 | Neurofibrillary tangles (HP:0002185) | 2.29700264 |
85 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.28823844 |
86 | Hypolipoproteinemia (HP:0010981) | 2.27752154 |
87 | Hypoalphalipoproteinemia (HP:0003233) | 2.24877119 |
88 | Pulmonary infiltrates (HP:0002113) | 2.24129372 |
89 | Protuberant abdomen (HP:0001538) | 2.22989349 |
90 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.21044898 |
91 | Bone pain (HP:0002653) | 2.19999349 |
92 | Amyloidosis (HP:0011034) | 2.14584062 |
93 | Hemoptysis (HP:0002105) | 2.13278862 |
94 | Spastic diplegia (HP:0001264) | 2.12898192 |
95 | Petechiae (HP:0000967) | 2.12280601 |
96 | Congenital sensorineural hearing impairment (HP:0008527) | 2.11904442 |
97 | Vasculitis (HP:0002633) | 2.11124187 |
98 | Abnormality of the gastric mucosa (HP:0004295) | 2.08882883 |
99 | Plantar hyperkeratosis (HP:0007556) | 2.08307221 |
100 | Micronodular cirrhosis (HP:0001413) | 2.06344034 |
101 | Onycholysis (HP:0001806) | 2.05693390 |
102 | Peripheral demyelination (HP:0011096) | 2.04779421 |
103 | Hydroureter (HP:0000072) | 2.04672480 |
104 | Mitral valve prolapse (HP:0001634) | 2.03480852 |
105 | Enlarged epiphyses (HP:0010580) | 2.02857677 |
106 | Wide cranial sutures (HP:0010537) | 2.02753847 |
107 | Abnormality of vitamin metabolism (HP:0100508) | 2.02104662 |
108 | Short hallux (HP:0010109) | 2.02023253 |
109 | Epidermoid cyst (HP:0200040) | 2.01041403 |
110 | Hypoglycemic coma (HP:0001325) | 2.00866326 |
111 | Confusion (HP:0001289) | 2.00541183 |
112 | Syncope (HP:0001279) | 2.00461143 |
113 | Abnormality of the 4th metacarpal (HP:0010012) | 1.99547969 |
114 | Woolly hair (HP:0002224) | 1.98202400 |
115 | Aneurysm (HP:0002617) | 1.97904388 |
116 | Abnormal tarsal ossification (HP:0008369) | 1.97405150 |
117 | Hydroxyprolinuria (HP:0003080) | 1.97250340 |
118 | Abnormality of proline metabolism (HP:0010907) | 1.97250340 |
119 | Hyperammonemia (HP:0001987) | 1.96399126 |
120 | Pustule (HP:0200039) | 1.96143798 |
121 | Cerebral aneurysm (HP:0004944) | 1.95089382 |
122 | Recurrent skin infections (HP:0001581) | 1.94933259 |
123 | Follicular hyperkeratosis (HP:0007502) | 1.93661265 |
124 | Abnormality of renin-angiotensin system (HP:0000847) | 1.93564724 |
125 | Abnormal ossification of hand bones (HP:0005921) | 1.93497499 |
126 | Abnormality of the nasal mucosa (HP:0000433) | 1.93076588 |
127 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.91950925 |
128 | Abnormality of small intestinal villus morphology (HP:0011472) | 1.91819016 |
129 | Villous atrophy (HP:0011473) | 1.91819016 |
130 | Chronic obstructive pulmonary disease (HP:0006510) | 1.91605818 |
131 | Obstructive lung disease (HP:0006536) | 1.91605818 |
132 | Ventricular tachycardia (HP:0004756) | 1.90748565 |
133 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.90391124 |
134 | Abnormality of the 1st metacarpal (HP:0010009) | 1.89441562 |
135 | Alkalosis (HP:0001948) | 1.88948697 |
136 | Dilatation of the ascending aorta (HP:0005111) | 1.88684861 |
137 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.88481189 |
138 | Fragile skin (HP:0001030) | 1.86936664 |
139 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.86822171 |
140 | Purpura (HP:0000979) | 1.86405533 |
141 | Peritonitis (HP:0002586) | 1.84862486 |
142 | Increased serum ferritin (HP:0003281) | 1.84487682 |
143 | Ventricular fibrillation (HP:0001663) | 1.84434045 |
144 | Ulnar bowing (HP:0003031) | 1.84304309 |
145 | Ureteral stenosis (HP:0000071) | 1.83402038 |
146 | Neoplasm of the rectum (HP:0100743) | 1.83383375 |
147 | Eczematoid dermatitis (HP:0000976) | 1.82637737 |
148 | Neonatal short-limb short stature (HP:0008921) | 1.82615554 |
149 | Apathy (HP:0000741) | 1.81930276 |
150 | Bone cyst (HP:0012062) | 1.81741568 |
151 | Abnormality of the costochondral junction (HP:0000919) | 1.81316297 |
152 | Dementia (HP:0000726) | 1.81297265 |
153 | Aplasia/Hypoplasia of the hallux (HP:0008362) | 1.79912983 |
154 | Gastrointestinal stroma tumor (HP:0100723) | 1.79586039 |
155 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 1.79215098 |
156 | Complement deficiency (HP:0004431) | 1.79190900 |
157 | Abnormality of the right ventricle (HP:0001707) | 1.79019584 |
158 | Aortic regurgitation (HP:0001659) | 1.78728065 |
159 | Stroke (HP:0001297) | 1.78020070 |
160 | Visceral angiomatosis (HP:0100761) | 1.77989059 |
161 | Diminished motivation (HP:0000745) | 1.76138410 |
162 | Microretrognathia (HP:0000308) | 1.75048285 |
163 | Pigmentary retinal degeneration (HP:0001146) | 1.74095785 |
164 | Hypotension (HP:0002615) | 1.73915461 |
165 | Spontaneous hematomas (HP:0007420) | 1.73787737 |
166 | Recurrent fungal infections (HP:0002841) | 1.73732280 |
167 | Pancreatitis (HP:0001733) | 1.73615519 |
168 | Hematochezia (HP:0002573) | 1.71968466 |
169 | Ureteral obstruction (HP:0006000) | 1.71545872 |
170 | Neoplasm of the small intestine (HP:0100833) | 1.71269232 |
171 | Fragile nails (HP:0001808) | 1.70613408 |
172 | Abnormality of carpal bone ossification (HP:0006257) | 1.69909900 |
173 | Type 1 muscle fiber predominance (HP:0003803) | 1.69345366 |
174 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.68919375 |
175 | Progressive sensorineural hearing impairment (HP:0000408) | 1.68330066 |
176 | Acanthocytosis (HP:0001927) | 1.68091996 |
177 | Periodontitis (HP:0000704) | 1.67921845 |
178 | Hoarse voice (HP:0001609) | 1.67451758 |
Rank | Gene Set | Z-score |
---|---|---|
1 | FRK | 6.07298655 |
2 | LMTK2 | 5.87422874 |
3 | ACVR1B | 5.46995755 |
4 | RIPK1 | 4.27687906 |
5 | MYLK | 3.98807028 |
6 | IRAK3 | 3.27185578 |
7 | MST1R | 3.17205357 |
8 | MST4 | 3.12372350 |
9 | PRKG2 | 3.00909992 |
10 | TTN | 2.68715561 |
11 | TESK1 | 2.52115592 |
12 | BLK | 2.44379324 |
13 | PIK3CA | 2.29670630 |
14 | GRK7 | 2.09072505 |
15 | MAP2K2 | 2.05016428 |
16 | PRPF4B | 2.02826745 |
17 | PTK6 | 1.96438751 |
18 | MAP3K2 | 1.94992997 |
19 | MAP4K1 | 1.93521017 |
20 | EPHB2 | 1.66187659 |
21 | ERN1 | 1.63941307 |
22 | BMPR2 | 1.63613472 |
23 | NME2 | 1.63534575 |
24 | MAP3K11 | 1.62884768 |
25 | DMPK | 1.61157606 |
26 | IKBKE | 1.60152322 |
27 | LATS1 | 1.58465850 |
28 | MAP3K10 | 1.54472792 |
29 | IRAK4 | 1.52343053 |
30 | TAOK2 | 1.49888949 |
31 | TESK2 | 1.39273946 |
32 | GRK6 | 1.38906286 |
33 | FGR | 1.36683682 |
34 | JAK3 | 1.35344627 |
35 | CSF1R | 1.32779767 |
36 | MET | 1.32726582 |
37 | EPHA2 | 1.30779321 |
38 | EPHB1 | 1.28992071 |
39 | DDR2 | 1.27670896 |
40 | IKBKB | 1.24377251 |
41 | LIMK1 | 1.22824675 |
42 | NUAK1 | 1.22090204 |
43 | PAK2 | 1.16121319 |
44 | FGFR4 | 1.14147452 |
45 | ZAP70 | 1.11904748 |
46 | ERBB2 | 1.10274179 |
47 | FER | 1.10260116 |
48 | MAP3K14 | 1.09148664 |
49 | TXK | 1.09052844 |
50 | MAP3K3 | 1.04340061 |
51 | ABL2 | 1.02929329 |
52 | PDGFRA | 1.02325951 |
53 | ADRBK2 | 1.01655713 |
54 | MAP2K1 | 1.00175162 |
55 | TGFBR2 | 0.99741838 |
56 | PIM2 | 0.95721335 |
57 | SYK | 0.92371924 |
58 | PTK2 | 0.92359440 |
59 | LYN | 0.91449676 |
60 | IRAK1 | 0.89427578 |
61 | FGFR2 | 0.86464069 |
62 | CSK | 0.84081133 |
63 | ITK | 0.80874876 |
64 | KIT | 0.80617717 |
65 | STK10 | 0.79350720 |
66 | MAP2K6 | 0.79044175 |
67 | EEF2K | 0.77734986 |
68 | PKN2 | 0.77348497 |
69 | MAP3K12 | 0.77034790 |
70 | MATK | 0.76950961 |
71 | MAP3K7 | 0.76809489 |
72 | ERBB4 | 0.75427370 |
73 | PAK4 | 0.72591762 |
74 | PRKAA2 | 0.70293466 |
75 | SCYL2 | 0.67537453 |
76 | INSRR | 0.66567346 |
77 | PIK3CG | 0.66302581 |
78 | MAP3K13 | 0.66059590 |
79 | FGFR3 | 0.65888136 |
80 | PDGFRB | 0.65634065 |
81 | CAMK2G | 0.64392914 |
82 | LCK | 0.62497410 |
83 | TYK2 | 0.61952873 |
84 | MAP3K5 | 0.61228503 |
85 | STK24 | 0.60731305 |
86 | GRK1 | 0.60620320 |
87 | GSK3A | 0.59616147 |
88 | PDK1 | 0.59225013 |
89 | LRRK2 | 0.59157119 |
90 | EPHA3 | 0.58379149 |
91 | MAP2K3 | 0.56141545 |
92 | OXSR1 | 0.55005819 |
93 | CDK6 | 0.54931829 |
94 | CAMK2D | 0.54783292 |
95 | ROCK1 | 0.53913369 |
96 | MAPK11 | 0.53784910 |
97 | PDK2 | 0.53522802 |
98 | KSR2 | 0.53289230 |
99 | STK39 | 0.52831929 |
100 | STK3 | 0.52340524 |
101 | PAK3 | 0.51040697 |
102 | TBK1 | 0.50710218 |
103 | PIM1 | 0.50002688 |
104 | DYRK1B | 0.47923703 |
105 | IRAK2 | 0.47553704 |
106 | SIK1 | 0.47528229 |
107 | CAMKK2 | 0.45882734 |
108 | BTK | 0.45735294 |
109 | CAMK2B | 0.45449150 |
110 | HCK | 0.44615789 |
111 | TYRO3 | 0.44286472 |
112 | PRKAA1 | 0.43914582 |
113 | DAPK2 | 0.43907034 |
114 | CHUK | 0.43266822 |
115 | TRIB3 | 0.42192523 |
116 | MOS | 0.41836018 |
117 | NME1 | 0.41469964 |
118 | JAK2 | 0.39674446 |
119 | JAK1 | 0.38552612 |
120 | BMX | 0.38433373 |
121 | MAP3K1 | 0.37852717 |
122 | SRC | 0.37364669 |
123 | RPS6KC1 | 0.35985028 |
124 | RPS6KL1 | 0.35985028 |
125 | CDC42BPA | 0.35698186 |
126 | PRKCD | 0.34665047 |
127 | MAPK7 | 0.33764929 |
128 | RPS6KB2 | 0.32815246 |
129 | TRPM7 | 0.32057045 |
130 | MAPK15 | 0.31629583 |
131 | TNIK | 0.31093335 |
132 | MAP3K8 | 0.30795153 |
133 | KDR | 0.30710559 |
134 | PRKACG | 0.29665895 |
135 | ABL1 | 0.29413028 |
136 | FYN | 0.28697255 |
137 | MAPK4 | 0.28126256 |
138 | PAK1 | 0.27946360 |
139 | MAPKAPK2 | 0.25941688 |
140 | INSR | 0.25260263 |
141 | PRKCA | 0.23138963 |
142 | RIPK4 | 0.22528811 |
143 | FGFR1 | 0.22413450 |
144 | PRKG1 | 0.21439676 |
145 | TAOK1 | 0.20458594 |
146 | TAOK3 | 0.20451119 |
147 | PDPK1 | 0.20170110 |
148 | ALK | 0.19787322 |
149 | SGK3 | 0.19553784 |
150 | RPS6KA2 | 0.19317218 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Sulfur metabolism_Homo sapiens_hsa00920 | 5.12053110 |
2 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.84360170 |
3 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 3.62621959 |
4 | Asthma_Homo sapiens_hsa05310 | 3.08681177 |
5 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.85658541 |
6 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.80640214 |
7 | Allograft rejection_Homo sapiens_hsa05330 | 2.75185540 |
8 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.69284336 |
9 | Bile secretion_Homo sapiens_hsa04976 | 2.60059588 |
10 | Other glycan degradation_Homo sapiens_hsa00511 | 2.50460440 |
11 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.45360139 |
12 | Histidine metabolism_Homo sapiens_hsa00340 | 2.43807058 |
13 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.38873369 |
14 | Mineral absorption_Homo sapiens_hsa04978 | 2.33538684 |
15 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.30627411 |
16 | Leishmaniasis_Homo sapiens_hsa05140 | 2.07689891 |
17 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.97936639 |
18 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.91309805 |
19 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.89490371 |
20 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.88027053 |
21 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.78826435 |
22 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.75264251 |
23 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.70983416 |
24 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.69895472 |
25 | Lysosome_Homo sapiens_hsa04142 | 1.68117485 |
26 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.66990833 |
27 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.66984944 |
28 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.66492791 |
29 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.65160742 |
30 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.64712027 |
31 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.57294433 |
32 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.56298149 |
33 | Tuberculosis_Homo sapiens_hsa05152 | 1.43540543 |
34 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.41485566 |
35 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.41359430 |
36 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.37183846 |
37 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.35760937 |
38 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.35551974 |
39 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.31712691 |
40 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.25660280 |
41 | Viral myocarditis_Homo sapiens_hsa05416 | 1.21915877 |
42 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.19856318 |
43 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.17055173 |
44 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.11513597 |
45 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.10823998 |
46 | ABC transporters_Homo sapiens_hsa02010 | 1.10036624 |
47 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.08624817 |
48 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.08189441 |
49 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.05450318 |
50 | Phagosome_Homo sapiens_hsa04145 | 1.04154352 |
51 | Influenza A_Homo sapiens_hsa05164 | 1.03033981 |
52 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.02979304 |
53 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.02413978 |
54 | Galactose metabolism_Homo sapiens_hsa00052 | 1.01856066 |
55 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.99601839 |
56 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.98964736 |
57 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.90698848 |
58 | Retinol metabolism_Homo sapiens_hsa00830 | 0.85937915 |
59 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.85855436 |
60 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.85314288 |
61 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.84700831 |
62 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.84494760 |
63 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.84225043 |
64 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.82936482 |
65 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.82175743 |
66 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.81971950 |
67 | Adherens junction_Homo sapiens_hsa04520 | 0.81759293 |
68 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.81313065 |
69 | Tight junction_Homo sapiens_hsa04530 | 0.81147516 |
70 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.80829993 |
71 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.79639874 |
72 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.79507113 |
73 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.78946939 |
74 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.78221236 |
75 | Amoebiasis_Homo sapiens_hsa05146 | 0.76865626 |
76 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.76197202 |
77 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.75985462 |
78 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.75976319 |
79 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.75837726 |
80 | Legionellosis_Homo sapiens_hsa05134 | 0.75833551 |
81 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.74157732 |
82 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.72674204 |
83 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.72223559 |
84 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.72184341 |
85 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.70992856 |
86 | Prion diseases_Homo sapiens_hsa05020 | 0.68685415 |
87 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.68094642 |
88 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.65703727 |
89 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.60949349 |
90 | Focal adhesion_Homo sapiens_hsa04510 | 0.60298139 |
91 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.57730594 |
92 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.57623106 |
93 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.57177380 |
94 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.56984707 |
95 | Insulin resistance_Homo sapiens_hsa04931 | 0.55140344 |
96 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.54333432 |
97 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.54292931 |
98 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.53931725 |
99 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.51560039 |
100 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.50525207 |
101 | Lysine degradation_Homo sapiens_hsa00310 | 0.50232292 |
102 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.50013017 |
103 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.49257515 |
104 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.48347197 |
105 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.46657202 |
106 | Carbon metabolism_Homo sapiens_hsa01200 | 0.46345691 |
107 | Salmonella infection_Homo sapiens_hsa05132 | 0.46275805 |
108 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.46180138 |
109 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.44394278 |
110 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.43861137 |
111 | Peroxisome_Homo sapiens_hsa04146 | 0.43560781 |
112 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.42893677 |
113 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.42743068 |
114 | Hepatitis C_Homo sapiens_hsa05160 | 0.42647883 |
115 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.39067757 |
116 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.38933830 |
117 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.38549951 |
118 | Platelet activation_Homo sapiens_hsa04611 | 0.35602887 |
119 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.35160898 |
120 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.34799156 |
121 | Salivary secretion_Homo sapiens_hsa04970 | 0.34721414 |
122 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.33539428 |
123 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.33444398 |
124 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.32832207 |
125 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.32612419 |
126 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.32029071 |
127 | Apoptosis_Homo sapiens_hsa04210 | 0.31954755 |
128 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.31598185 |
129 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.31468028 |
130 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.30455933 |
131 | Pertussis_Homo sapiens_hsa05133 | 0.30218468 |
132 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.30080201 |
133 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.29403644 |
134 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.29342314 |
135 | Shigellosis_Homo sapiens_hsa05131 | 0.29131602 |
136 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.28962977 |
137 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.28861076 |
138 | Measles_Homo sapiens_hsa05162 | 0.28116550 |
139 | Bladder cancer_Homo sapiens_hsa05219 | 0.25914407 |
140 | Hepatitis B_Homo sapiens_hsa05161 | 0.25441880 |
141 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.24760636 |
142 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.24439032 |
143 | Malaria_Homo sapiens_hsa05144 | 0.23678216 |
144 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.22735627 |
145 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.22321854 |
146 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.22076719 |